Longnecker R - Search Results

1

In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2).

Rochford R, Miller CL, Cannon MJ, Izumi KM, Kieff E, Longnecker R. Rochford R, et al. Among authors: longnecker r. Arch Virol. 1997;142(4):707-20. doi: 10.1007/s007050050113. Arch Virol. 1997. PMID: 9170499 Free article.

2

Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.

Marchini A, Longnecker R, Kieff E. Marchini A, et al. Among authors: longnecker r. J Virol. 1992 Aug;66(8):4972-81. doi: 10.1128/JVI.66.8.4972-4981.1992. J Virol. 1992. PMID: 1321281 Free PMC article.

3

An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.

Burkhardt AL, Bolen JB, Kieff E, Longnecker R. Burkhardt AL, et al. Among authors: longnecker r. J Virol. 1992 Aug;66(8):5161-7. doi: 10.1128/JVI.66.8.5161-5167.1992. J Virol. 1992. PMID: 1321296 Free PMC article.

4

The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.

Longnecker R, Miller CL, Miao XQ, Marchini A, Kieff E. Longnecker R, et al. J Virol. 1992 Nov;66(11):6461-9. doi: 10.1128/JVI.66.11.6461-6469.1992. J Virol. 1992. PMID: 1328675 Free PMC article.

5

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A. Henderson S, et al. Among authors: longnecker r. Cell. 1991 Jun 28;65(7):1107-15. doi: 10.1016/0092-8674(91)90007-l. Cell. 1991. PMID: 1648447

6

An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase.

Longnecker R, Druker B, Roberts TM, Kieff E. Longnecker R, et al. J Virol. 1991 Jul;65(7):3681-92. doi: 10.1128/JVI.65.7.3681-3692.1991. J Virol. 1991. PMID: 1710288 Free PMC article.

7

A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.

Longnecker R, Kieff E. Longnecker R, et al. J Virol. 1990 May;64(5):2319-26. doi: 10.1128/JVI.64.5.2319-2326.1990. J Virol. 1990. PMID: 2157888 Free PMC article.

8

Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.

Miller CL, Longnecker R, Kieff E. Miller CL, et al. Among authors: longnecker r. J Virol. 1993 Jun;67(6):3087-94. doi: 10.1128/JVI.67.6.3087-3094.1993. J Virol. 1993. PMID: 7684459 Free PMC article.

9

Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.

Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB, Longnecker R. Miller CL, et al. Among authors: longnecker r. Infect Agents Dis. 1994 Apr-Jun;3(2-3):128-36. Infect Agents Dis. 1994. PMID: 7812651 Review.

10

Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.

Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, Bolen JB, Kieff E. Miller CL, et al. Among authors: longnecker r. Immunity. 1995 Feb;2(2):155-66. doi: 10.1016/s1074-7613(95)80040-9. Immunity. 1995. PMID: 7895172 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters